Skip to main content
OpenTrials

Clinical trial condition

Candidiasis

Explore clinical trials studying Candidiasis. Study availability and eligibility vary by location and protocol.

172 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Candidiasis trial results

Completed

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

NCT00413218

Conditions
Bacterial Infections and Mycoses, Candidemia, Candidiasis, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Somero Research Corporation Palm Desert, California, United States
  • University of California Davis Health System Sacramento, California, United States
  • University of California at San Francisco San Francisco, California, United States
View all 113 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

NCT03059992

Conditions
Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +44 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
View all 37 locations
View Trial Details
Completed

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

NCT05399641

Conditions
Bacterial Infections and Mycoses, Candidiasis, Candidiasis, Vulvovaginal, +14 more
Locations
  • Precision Trials, AZ Phoenix, Arizona, United States
  • Women's Healthcare Research San Diego, California, United States
  • Wake Research (MCCR) San Diego, California, United States
  • New Age Medical Research Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)

NCT03363841

Conditions
Bacterial Infections and Mycoses, Candidemia, Candidiasis, +10 more
Locations
  • Scynexis, Inc. Jersey City, New Jersey, United States
  • St John's Medical College and Hospital Bangalore, Karnataka, India
  • Amrita Institute of Medical Sciences (AIMS) Kanayannur, Kochi, India
  • Institute of Critical Care Medicine Max Super Specialty Hospital Sāket, New Delhi, India
View Trial Details
Completed

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

NCT02244606

Conditions
Bacterial Infections and Mycoses, Candidemia, Candidiasis, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Miami Miami, Florida, United States
View all 30 locations
View Trial Details

Related conditions